InvestSMART

Australian Pharmaceutical Industries Limited (ASX: API) - Announcements

DELISTED - Current share price for API : $1.530

ASX company news and announcements for Australian Pharmaceutical Industries Limited (API) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Pharmaceutical Industries Limited (API) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Pharmaceutical Industries Limited (API), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Pharmaceutical Industries Limited (API)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B 2 Nov 2018 10:01AM $1.560 $1.530 fallen by 1.92%
- FY18 - Results Presentation 18 Oct 2018 9:00AM $1.720 $1.530 fallen by 11.05%
- FY18 Results - media release 18 Oct 2018 8:57AM $1.720 $1.530 fallen by 11.05%
- Dividend/Distribution - API 18 Oct 2018 8:52AM $1.720 $1.530 fallen by 11.05%
- Appendix 4E and FY18 Financial Report 18 Oct 2018 8:49AM $1.720 $1.530 fallen by 11.05%
- API FY18 Financial Results 12 Oct 2018 4:40PM $1.635 $1.530 fallen by 6.42%
- Becoming a substantial holder from CBA 21 Sep 2018 2:28PM $1.888 $1.530 fallen by 18.94%
- Ceasing to be a substantial holder from CBA 14 Sep 2018 12:21PM $1.863 $1.530 fallen by 17.85%
- Becoming a substantial holder from CBA 12 Sep 2018 2:53PM $1.843 $1.530 fallen by 16.96%
- Ceasing to be a substantial holder from CBA 6 Sep 2018 1:57PM $1.738 $1.530 fallen by 11.94%
- Becoming a substantial holder from CBA 5 Sep 2018 4:54PM $1.825 $1.530 fallen by 16.16%
- Ceasing to be a substantial holder from CBA 3 Sep 2018 3:48PM $1.825 $1.530 fallen by 16.16%
- Becoming a substantial holder from CBA 31 Aug 2018 11:47AM $1.848 $1.530 fallen by 17.19%
- First stage of Clearskincare Clinics acquisition complete 1 Aug 2018 8:09AM $1.690 $1.530 fallen by 9.47%
- Ceasing to be a substantial holder from CBA 5 Jul 2018 5:03PM $1.495 $1.530 risen by 2.34%
- Becoming a substantial holder from CBA 2 Jul 2018 4:14PM n/a $1.530 n/a
- API Briefing 25 June 2018 - Clearskincare Clinics 25 Jun 2018 8:37AM $1.355 $1.530 risen by 12.92%
- API Presentation - Acquisition of Clearskincare Clinics 25 Jun 2018 8:33AM $1.355 $1.530 risen by 12.92%
- API to acquire Clearskincare Clinics 25 Jun 2018 8:32AM $1.355 $1.530 risen by 12.92%
- Letter to Shareholders - interim dividend payment 1 Jun 2018 8:40AM $1.355 $1.530 risen by 12.92%
- API HY18 Results Presentation 19 Apr 2018 9:09AM $1.505 $1.530 risen by 1.66%
- API HY18 Results ASX Release 19 Apr 2018 9:05AM $1.505 $1.530 risen by 1.66%
- Dividend/Distribution - API 19 Apr 2018 9:01AM $1.505 $1.530 risen by 1.66%
- API Half Yearly Report and Accounts 19 Apr 2018 8:58AM $1.505 $1.530 risen by 1.66%
- API HY18 Financial Results 13 Apr 2018 6:50PM $1.495 $1.530 risen by 2.34%

226 - 250 of 477 results

Page 10 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.